Flenner, F., Friedrich, F. W., Ungeheuer, N., Christ, T., Geertz, B., Reischmann, S., Wagner, S., Stathopoulou, K., Söhren, K., Weinberger, F., Schwedhelm, E., Cuello, F., Maier, L. S., Eschenhagen, T., & Carrier, L. (2016). ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy. Cardiovascular research, 109, 90–102. http://access.bl.uk/ark:/81055/vdc_100173233672.0x000055